Table 3

Prevalence of MetS among Sami and non-Sami, by age groups and gender (N=15 112)

Men (years)European cut-off of WCNIH cut-off of WC
Sami (N=650)
n (%)
Non-Sami (N=917)
n (%)
p Value*Sami (N=315)
n (%)
Non-Sami (N=728)
n (%)
p Value*
36–49194 (22.3)429 (26.0)0.03889 (10.2)203 (12.3)0.118
50–59229 (27.2)440 (29.7)0.202115 (13.7)238 (16.1)0.121
60–79227 (26.9)489 (30.6)0.055111 (13.1)287 (18.0)0.002
p Value†0.029<0.00010.05<0.0001
Women (years)Sami (N=790)
n (%)
Non-Sami (N=1521)
n (%)
Sami (N=588)
n (%)
Non-Sami (N=1091)
n (%)
36–49232 (24.4)369 (19.1)0.006161 (16.2)263 (13.6)0.056
50–59248 (31.5)455 (29.4)0.291177 (22.5)309 (20.0)0.155
60–79310 (38.7)697 (39.6)0.641250 (31.2)519 (29.5)0.393
p Value†0.004<0.0001<0.0001<0.0001
  • 2 tests for differences in MetS prevalence of Sami versus non-Sami.

  • †Age effect tested by logistic regression with age as a continuous variable.

  • MetS, metabolic syndrome; NIH, National Institute of Health; WC, waist circumference.